Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,888
Total Claims
$1.1M
Drug Cost
1,065
Beneficiaries
$1,069
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-52%
Opioid rate vs peers
1.1% vs 2.2% avg
-24%
Cost per patient vs peers
$1,069 vs $1,411 avg
+5%
Brand preference vs peers
11.2% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.1%
Opioid Rate
127
Opioid Claims
$1,696
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,315 claims · $873K
Generic: 10,477 claims · $262K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 165 | $148K |
| Empagliflozin | 86 | $130K |
| Semaglutide | 69 | $95K |
| Sitagliptin Phosphate | 47 | $64K |
| Rivaroxaban | 39 | $54K |
| Dapagliflozin Propanediol | 29 | $31K |
| Fluticasone/Vilanterol | 46 | $24K |
| Rosuvastatin Calcium | 951 | $21K |
| Insulin Glargine,hum.Rec.Anlog | 15 | $18K |
| Linagliptin | 11 | $18K |
| Vortioxetine Hydrobromide | 19 | $17K |
| Evolocumab | 22 | $16K |
| Semaglutide | 11 | $13K |
| Budesonide/Formoterol Fumarate | 30 | $13K |
| Tirzepatide | 11 | $12K |
Prescribing Profile
Patient Profile
76
Avg Age
40%
Female
1.12
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About